drugset / Trial / NCT00189072
Effects of Gabapentin in the Treatment of Neuropathic Pain on Driving Performance and Cognition
RandomizedCrossoverDouble-blindTreatment
Summary
The aim of this study was to explore the effects of pain on the one hand and the effects of treatment of pain with gabapentin (900, 1200, 1800 or 2400 mg) on the other hand on actual driving performance and several laboratory tests in patients with neuropathic pain. It was hypothesized that gabapentin might influence performance after acute but not after subchronic administration.
Timeline
- Start
- 2003-04
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gabapentin | Small molecule | 900 mg | — |
| Subject | Gabapentin | Small molecule | 1200 mg | — |
| Subject | Gabapentin | Small molecule | 1800 mg | — |
| Subject | Gabapentin | Small molecule | 2400 mg | — |